Cargando…
Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice
OBJECTIVES: To gain insights into the usage of factor VIII (FVIII) products by patients diagnosed with moderate/severe hemophilia A, and to assess the impact and perceived importance of product storage. METHODS: In this study, 200 patients diagnosed with moderate or severe hemophilia A across seven...
Autores principales: | Tischer, Bernd, Marino, Renato, Napolitano, Mariasanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875588/ https://www.ncbi.nlm.nih.gov/pubmed/29618923 http://dx.doi.org/10.2147/PPA.S151812 |
Ejemplares similares
-
The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A
por: Napolitano, Mariasanta, et al.
Publicado: (2019) -
Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits
por: Schiavoni, Mario, et al.
Publicado: (2019) -
Patient and parent preferences for characteristics of prophylactic treatment in hemophilia
por: Furlan, Roberto, et al.
Publicado: (2015) -
Patient preferences in the treatment of hemophilia A: A latent class analysis
por: Mühlbacher, Axel C., et al.
Publicado: (2021) -
Understanding patient preferences and willingness to pay for hemophilia therapies
por: Chaugule, Shraddha S, et al.
Publicado: (2015)